-
-
The Cost of Attacking the Pharmaceutical Industry
Trump
Trump's policies during his second term have rocked the U.S. scientific community, slashing NIH funding, threatening pharmaceutical innovation, and reshaping the global research landscape amid rising concerns about America's future in science.
-
NIH Cuts and the Future of U.S. Biopharma
NIH
Trump's proposed NIH budget cuts, agency consolidations, and funding restrictions could reshape U.S. biomedical research, strain U.S.-China collaborations, and shift national priorities toward AI and space tech.
-
Trump's Presidency: Impact on the U.S. Biopharma Industry
FDA
Explore the implications of Trump's return on U.S. biopharma: healthcare cost reforms, IRA adjustments, reshoring manufacturing, and FDA/NIH shifts. Key focus areas for Chinese pharma include supply chain resilience and navigating new cross-border data regulations.
-
-
Tecovirimat Ineffective for Clade I Mpox in DRC Study
NIH
A recent NIH study in the Democratic Republic of the Congo found that tecovirimat does not improve clade I mpox lesion resolution. Despite this, mortality rates were lower than average. The study emphasizes the need for more research on effective treatments and vaccines for clade I mpox.
-
-
-
-
驻马店市|
汽车|
双柏县|
陆川县|
吉水县|
泊头市|
织金县|
庆安县|
德令哈市|
鲁山县|
读书|
正阳县|
新闻|
扶沟县|
务川|
齐河县|
平安县|
岱山县|
措美县|
高阳县|
章丘市|
康定县|
南涧|
依兰县|
确山县|
洱源县|
马公市|
肇东市|
孟津县|
夹江县|
尼木县|
阿克苏市|
万荣县|
牡丹江市|
无为县|
新安县|
汝州市|
济源市|
吉水县|
宁国市|
通化市|